A Phase III international study of osimertinib as maintenance therapy in patients with locally advanced,unresectable EGFR mutation-positive NSCLC whose disease has not progressed following definitive platinum-based chemoradiation therapy China patient EGFR genetic biomarker data
| Title | A Phase III international study of osimertinib as maintenance therapy in patients with locally advanced,unresectable EGFR mutation-positive NSCLC whose disease has not progressed following definitive platinum-based chemoradiation therapy China patient EGFR genetic biomarker data |
|---|---|
| Description | This study used PCR to detect EGFR status, obtained EGFR test results of tumor sections of 80 patients and plasma EGFR test results of 43 patients, and merged them into an Excel file. |
| Organism | Homo sapiens |
| Data Type | Genetic Biomarkers |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA027946 |
| Release Date | 2024-07-17 |
| Submitter | shun Lu (shunlu_shchest@sina.com) |
| Organization | Shanghai Chest Hospital |
| Submission Date | 2024-07-10 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX006859-01 | China patient EGFR result | 1 | Genetic Biomarkers | 15.3 KB | xlsx | 0 | Unavailable |